- Marinomed has signed a binding term sheet with a Swiss pharma partner for the development and marketing of Budesolv for the Swiss market
- With this Marinomed is eligible to receive milestone payments and royalties
- Switzerland to serve as a reference country for certain markets abroad
The full press release is available as download here: